| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/27/2007 | CA2098253C Method for producing ectoprotein of hepatitis c virus |
| 02/22/2007 | WO2007021841A2 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 02/22/2007 | WO2007021733A2 Methods and compositions for enhancing protein folding |
| 02/22/2007 | WO2007021353A2 Improving antibody expression using vectors containing insulator elements |
| 02/22/2007 | WO2007021255A1 Antibodies to alpha-synuclein |
| 02/22/2007 | WO2007021002A1 Immunodetection method for influenza virus h5 subtype |
| 02/22/2007 | WO2007020965A1 Method of inhibiting function of cytosolic protein by single chain antibody and use thereof |
| 02/22/2007 | WO2007020889A1 Novel mucin glycoprotein and use thereof |
| 02/22/2007 | WO2007020256A1 Method for making mature insulin polypeptides |
| 02/22/2007 | WO2007001895A3 Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase |
| 02/22/2007 | WO2006114787A3 Wood-rotting basidiomycetes for production of ligninolytic enzymes |
| 02/22/2007 | WO2006084050A3 Libraries and methods for isolating antibodies |
| 02/22/2007 | WO2006063302A3 Variants of glycogen synthase kinase 3 and uses thereof |
| 02/22/2007 | WO2005121338A9 Anti-perp antibody |
| 02/22/2007 | WO2005111060A3 Molecules involved in protein folding and methods op identifying them |
| 02/22/2007 | WO2004108748A3 Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses |
| 02/22/2007 | WO2004058800A3 Mammalian cell culture processes for protein production |
| 02/22/2007 | US20070044166 P2Y4 Receptor transgenic and knockout non-human mammals |
| 02/22/2007 | US20070044163 Interferon gamma-like protein |
| 02/22/2007 | US20070043211 Mammalian transforming growth factor beta-9 |
| 02/22/2007 | US20070043209 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/22/2007 | US20070042978 Nf-hev compositions and methods of use |
| 02/22/2007 | US20070042958 Immunoglobulins; myostatins; for treatment of neuronal diseases, muscle and bone conditions, and metabolic disorders; improved solubility, pharmacokinetics |
| 02/22/2007 | US20070042954 Soluble G-protein coupled receptors (sGPCR); corticotropin releasing factor receptor type 2 (sCRFR2) attached to affinity tag, fluorescent label, immunoglobulin domain or conjugated to polyoxyethylene glycol; skin, gastrointestinal, bipolar, and psychological disorders; drug abuse; anxiolytic agents |
| 02/22/2007 | US20070042945 Nouvelles compositions et methods de traitement du psoriasis |
| 02/22/2007 | US20070042941 Galectin 9-inducing factors |
| 02/22/2007 | US20070042485 Modified TRAP protein for producing nano-scale electrical devices, and a method for producing such a protein |
| 02/22/2007 | US20070042474 Corynebacterium glutamicum genes encoding novel proteins |
| 02/22/2007 | US20070042472 Mammalian transforming growth factor beta-9 |
| 02/22/2007 | US20070042471 Homogeneous preparations of il-28 and il-29 |
| 02/22/2007 | US20070042470 Homogeneous preparations of il-28 and il-29 |
| 02/22/2007 | US20070042469 Homogeneous preparations of IL-29 produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 02/22/2007 | US20070042468 Interferon-like protein zcyto21 |
| 02/22/2007 | US20070042467 NIMA interacting proteins |
| 02/22/2007 | US20070042466 Il-1 related polypeptides |
| 02/22/2007 | US20070042465 Mammalian transforming growth factor beta-9 |
| 02/22/2007 | US20070042464 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 02/22/2007 | US20070042463 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof |
| 02/22/2007 | US20070042462 Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb |
| 02/22/2007 | US20070042461 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 02/22/2007 | US20070042460 Oxidation of peptides |
| 02/22/2007 | US20070042459 Industrially producing dipeptides easily and inexpensively without going through a complex synthesis |
| 02/22/2007 | US20070042458 Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| 02/22/2007 | US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 02/22/2007 | US20070042445 Method for demonstration of a molecular event in a cell by means of fluorescent marker proteins |
| 02/22/2007 | US20070042433 Neuregulin protein regulation of synaptic proteins |
| 02/22/2007 | US20070042420 Liver tumor marker sequences |
| 02/22/2007 | US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule |
| 02/22/2007 | US20070042415 Anti-fused antibodies |
| 02/22/2007 | US20070042404 Compositions and method for detecting endonuclease activity |
| 02/22/2007 | US20070042403 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases |
| 02/22/2007 | US20070042395 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 02/22/2007 | US20070042391 useful as molecular targets for diagnostics, prophylaxis and treatment of pathological conditions; for use in generating agents for prevention and treatment of infection |
| 02/22/2007 | US20070042387 Promoter, promoter control elements, and combinations, and uses thereof |
| 02/22/2007 | US20070042379 having at least 35% amino acid sequence identity with T7 Endo I, two catalytic centers separated by a beta -bridge, and a mutation of at least one amino acid in the beta -bridge that has an effect of altering cleavage activity; reduced toxicity in a host cell permitting over-expression of the enzyme |
| 02/22/2007 | US20070042378 Regulation of prokaryotic gene expression with zinc finger proteins |
| 02/22/2007 | US20070042375 Isolated berovin photoprotein and use thereof |
| 02/22/2007 | US20070042363 Novel polypeptide and nucleic acid encoding the same |
| 02/22/2007 | US20070042359 E-protein specific immunoglobulin for use in treatment and prevention of viral infection |
| 02/22/2007 | US20070042345 Polypeptide having intracellular calcium ion indicator function |
| 02/22/2007 | US20070042080 Novel food production process |
| 02/22/2007 | US20070042047 Vaccines |
| 02/22/2007 | US20070041987 Fragments or polymers of albumin with tunable vascular residence time for use in therapeutic delivery and vaccine development |
| 02/22/2007 | US20070041983 Method for treating tumors using anti-osteopontin antibodies |
| 02/22/2007 | US20070041982 ILT3 binding molecules and uses therefor |
| 02/22/2007 | US20070041980 CA6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/22/2007 | US20070041979 Proteolysis resistant antibody preparations |
| 02/22/2007 | US20070041977 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 02/22/2007 | US20070041974 Cytokine zalpha11 ligand antibodies |
| 02/22/2007 | US20070041972 Antibodies and fusion proteins that include engineered constant regions |
| 02/22/2007 | US20070041970 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 02/22/2007 | US20070041969 Apo-2DcR |
| 02/22/2007 | US20070041967 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 02/22/2007 | US20070041966 Polypeptides including modified constant regions |
| 02/22/2007 | US20070041965 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/22/2007 | US20070041964 WISP polypeptides and nucleic acids encoding same |
| 02/22/2007 | US20070041958 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 02/22/2007 | US20070041956 Vaccine immunotherapy for immune suppressed patients |
| 02/22/2007 | US20070041945 Novel method for down-regulation of amyloid |
| 02/22/2007 | US20070041936 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/22/2007 | CA2618878A1 Compositions of trna and uses thereof |
| 02/22/2007 | CA2618791A1 Novel mucin-type glycoprotein and use thereof |
| 02/22/2007 | CA2611465A1 Improving antibody expression using vectors containing insulator elements |
| 02/21/2007 | EP1754789A2 Bacillus strains and pesticidal proteins |
| 02/21/2007 | EP1754788A2 Prostate-specific membrane antigen and uses thereof |
| 02/21/2007 | EP1754787A2 Methods for producing members of specific binding pairs |
| 02/21/2007 | EP1754786A2 Herbicide resistant products based on structure-based method |
| 02/21/2007 | EP1754784A2 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 02/21/2007 | EP1754719A2 Anti-osteopontin antibody and use thereof |
| 02/21/2007 | EP1754718A2 Inactivation resistant factor VIII |
| 02/21/2007 | EP1754485A1 Remedy for neurodegenerative diseases |
| 02/21/2007 | EP1753880A2 Methods for treating cancer using anti-wnt2 monoclonal antibodies and sirna |
| 02/21/2007 | EP1753871A2 Antibodies and related molecules that bind to psca proteins |
| 02/21/2007 | EP1753779A2 Interferon-alpha polypeptides and conjugates |
| 02/21/2007 | EP1517913B1 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
| 02/21/2007 | EP1260144B1 Process for producing soybean protein hydrolyzate |
| 02/21/2007 | EP1232177B1 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 02/21/2007 | EP1231279B1 Process for producing tripeptides |
| 02/21/2007 | EP1163853B1 Method of strengthenig the taste of sodium chloride, agent for strengthening the taste of sodium chloride, sodium chloride-taste seasoning and food having strengthened taste of sodium chloride |
| 02/21/2007 | EP1137812B1 Dna-protein fusions and uses thereof |